3Needleman P, Isakson P C. The discovery and function of COX-2. J Rheumatol, 1997, 24 (Supp149):6-8.
4Amit S K, Alan B M, Brendan C C, et al. Ester and amide derivatives of the nonsteroidal anti-inflammatory drug,indomethacin, as selective cyclooxygenase-2 inhibitors. J Med Chem, 2000, 43(15): 2860~2870.
5Hawkey C J. COX-2 inhibitor. Lancet, 1999, 353(9149):307-314.
6Willoughby D A,Moore A R,Colville P R.Cox-1,Cox-2 andCox-3and the future treatment of chronic inflammatory disease.Lancet,2000,355(9204):646-648.
7Vane J R, Booting R M. Mechanism of action of nonsteroidal anti-inflammatory drugs. Am J Med, 1998, 104(3A):2S-8S.
8Christopher J. Nonsteroidal anti-inflammatory drugs and the gastrointestinal tract: consensus and controversy. Am J Med, 2001, 110(IA): 1S-3S.
9Raymond V G. Merck announce voluntary worldwide withdrawal of VIOXX [DB/OL]. http://www.vioxx.com/rofecoxib/vioxx/consumer/index.jsp, 2004-09-30.
10Pfizer statement on new information regarding cardiovascular safety of celebrex [DB/OL]. http://www.celebrex.com/cardiovascular_safety_ of_celebrex_tp.asp, 2004-12-17.
